CRC Macrodissect AI

Looking Back: Reviewing 2025 at Indica Labs

As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement.

Looking Back: Reviewing 2025 at Indica Labs Read More »

Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI

Albuquerque, NM, April 17, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today the expansion of their macrodissection suite with the launch of CRC Macrodissect AI. This expanded portfolio of AI powered tools by Indica Labs will facilitate a macrodissection workflow that minimizes human error and improves efficiency across multiple disease sites. Utilizing the integrative power of artificial intelligence and digital pathology, CRC Macrodissect AI will advance the field of molecular pathology and offer unparalleled insight into colorectal carcinoma.

Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI Read More »

CRC Macrodissect AI and Breast HER2 AI Sneak Peek

27 March 2025 | Learn about the latest advancements in AI-powered pathology. In this webinar, we’ll introduce CRC Macrodissect AI, an advanced solution designed to assist in colorectal cancer tumor content scoring and selecting regions for downstream macrodissection.

CRC Macrodissect AI and Breast HER2 AI Sneak Peek Read More »

Scroll to Top